![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2017
Anzahl der Publikationen: 3
2017
Fernandez-Torron, R.; James, M.; Diaz Manera, J.; Mayhew, A.; Llauger Rosello, J.; Moore, U.; Smith, F.; Jacobs, M.; Carlier, P.; Rufibach, L.; Spuler, S.; Day, J. W.; Jones, K. J.; Bharucha-Göbel, D. X.; Salort-Campana, E.; Pestronk, A.; Walter, M. C.; Paradas, C.; Stojkovic, T.; Takeda, S.; Bravver, E.; Pegoraro, E.; Mendell, J. R.; Bushby, K. und Straub, V.
(2017):
Functional outcome measures and muscle MRI pattern recognition in dysferlinopathy: The JAIN COS Study.
In: European Journal of Neurology, Bd. 24: S. 96-97
James, M.; Jacobs, M.; Mayhew, A.; Feng, J.; Spuler, S.; Day, J.; Jones, K.; Bharucha-Göbel, D.; Salort-Campana, E.; Pestronk, A.; Walter, M.; Paradas, C.; Stojkovic, T.; Mori-Yoshimura, M.; Bravver, E.; Diaz-Manera, J.; Pegoraro, E.; Mendell, J.; Bushby, K. und Straub, V.
(2017):
Clinical outcome study of dysferlinopathy: what are the best outcome measures for dysferlinopathy patients?
In: Neuromuscular Disorders, Bd. 27:
S227-S227
Torron, R. Fernandez; Harris, E.; Bourke, J.; Bettinson, K.; Hilsden, H.; Spuler, S.; Day, J.; Jones, K.; Bharucha-Göbel, D.; Salort-Campana, E.; Pestronk, A.; Walter, M.; Paradas, C.; Stojkovic, T.; Mori-Yoshimura, M.; Bravver, E.; Diaz-Manera, J.; Pegoraro, E.; Mendell, J.; Bushby, K. und Straub, V.
(2017):
Is cardiac dysfunction a feature of dysferlinopathy? Data from the clinical outcome study of dysferlinopathy.
In: Neuromuscular Disorders, Bd. 27:
S145-S145